MED31 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.850400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.189600E-01
Normal-vs-Stage2
4.683400E-01
Normal-vs-Stage3
4.731400E-01
Normal-vs-Stage4
6.052200E-01
Stage1-vs-Stage2
3.511400E-01
Stage1-vs-Stage3
3.969800E-01
Stage1-vs-Stage4
4.712000E-01
Stage2-vs-Stage3
7.866200E-01
Stage2-vs-Stage4
9.509200E-01
Stage3-vs-Stage4
8.159200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.240400E-01
Normal-vs-AfricanAmerican
3.146200E-01
Normal-vs-Asian
1.394370E-01
Caucasian-vs-AfricanAmerican
2.293000E-01
Caucasian-vs-Asian
5.083700E-02
AfricanAmerican-vs-Asian
5.416400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.641600E-01
Normal-vs-Female
9.572800E-01
Male-vs-Female
1.237560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.653800E-01
Normal-vs-Age(41-60Yrs)
9.050600E-01
Normal-vs-Age(61-80Yrs)
6.303000E-01
Normal-vs-Age(81-100Yrs)
2.495600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.102400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.686200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.149600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.642400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.128100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.008200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.300400E-01
Normal-vs-Daily Drinker
9.622200E-01
Normal-vs-Weekly Drinker
6.321800E-01
Normal-vs-Occasional Drinker
9.955200E-01
Normal-vs-Social Drinker
8.480400E-01
Non Drinker-vs-Daily Drinker
1.846590E-01
Non Drinker-vs-Weekly Drinker
4.204600E-01
Non Drinker-vs-Occasional Drinker
7.381600E-02
Non Drinker-vs-Social Drinker
2.325200E-01
Daily Drinker-vs-Weekly Drinker
4.635600E-01
Daily Drinker-vs-Occasional Drinker
9.168800E-01
Daily Drinker-vs-Social Drinker
7.091600E-01
Weekly Drinker-vs-Occasional Drinker
4.113200E-01
Weekly Drinker-vs-Social Drinker
6.653800E-01
Occasional Drinker-vs-Social Drinker
7.227200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.252600E-01
Normal-vs-Grade 2
8.078800E-01
Normal-vs-Grade 3
7.848800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.312100E-02
Grade 1-vs-Grade 3
2.738500E-02
Grade 1-vs-Grade 4
9.252600E-01
Grade 2-vs-Grade 3
5.141800E-01
Grade 2-vs-Grade 4
8.078800E-01
Grade 3-vs-Grade 4
7.848800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.110000E-01
Normal-vs-NonDiabetic
9.264000E-01
Diabetic-vs-NonDiabetic
8.335100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.092030E-01
Normal-vs-NoPancreatitis
7.848600E-01
Pancreatitis-vs-NoPancreatitis
5.669900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.607000E-01
Normal-vs-N1
5.355800E-01
N0-vs-N1
1.837590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.048200E-01
Normal-vs-TP53-NonMutant
8.674600E-01
TP53-Mutant-vs-TP53-NonMutant
7.303300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
